Introduction: Garbhini Pandu, an anaemic state occurring during pregnancy, is described in Ayurveda as a condition marked by fatigue, pallor and reduced strength. In modern terms, it parallels iron-deficiency anaemia, a common maternal health challenge. Iron–Folic Acid (IFA) remains the standard therapy for improving haemoglobin and preventing pregnancy complications. Comparing two IFA regimens can help understand their relative benefits in correcting anaemia and easing symptoms of Garbhini Pandu. This study evaluates their clinical usefulness in pregnant women with this condition. Objectives: To compare the effect of Efficacy of Dadimavaleha as an Adjuvant to Iron Folic Acid in one group and only Iron- Folic Acid in other group on Haemoglobin level. And also compare the clinical symptoms (Pallor, Weakness, and Anorexia) in both groups. Methods: Pregnant women diagnosed with Garbhini Pandu were selected for the study and assigned into two groups through simple random allocation. Group A received the Dadim Avleha with IFA Tablet while Group B was given a modified IFA schedule as designed for the trial. Initial evaluation included haemoglobin and symptoms both groups continued their respective treatments for a fixed period. Improvement in blood parameters and clinical signs was recorded and compared to assess the relative effectiveness of the two regimens. Expected Result: Women receiving the combined treatment of Dadimavaleha with Iron–Folic Acid are expected to show improvement in anaemia than those taking only Iron–Folic Acid. this group may also experience fewer stomach-related complaints, which commonly occur with iron tablets. The combination is likely to produce a better rise in haemoglobin and Symptoms of Garbhini Pandu such as general weakness and Anorexia are expected to reduce more quickly in the combination group because Dadimavaleha supports digestion and enhances nutrient uptake. Conclusion: It will be drawn after obtaining the results of the study.